正压呼吸器市场规模、份额和成长分析（按产品类型、应用、最终用户和地区）- 产业预测 2025-2032

预计 2023 年正压呼吸器的市场规模将达到 22.7 亿美元，并从 2024 年的 23.9 亿美元增长到 2032 年的 35.8 亿美元，预测期内（2025-2032 年）的复合年增长率为 5.2%。

全球正压呼吸器(PAP)设备市场正在持续成长，这得益于人们对睡眠呼吸中止症等睡眠相关呼吸障碍的认识和诊断的不断提高。这些情况对整体健康有重大影响，推动了对有效治疗方案的需求，例如非侵入性、呼吸增强型持续性阳压呼吸器(CPAP) 和双水平气道正压通气 (BiPAP) 机器。主要成长动力包括医疗保健支出的增加、提高舒适度的技术进步以及更容易出现睡眠障碍的老龄化人口。製造商、医疗保健提供者和研究机构之间的合作正在推动创新。然而，包括患者依从性、成本问题和监管障碍在内的挑战正迫使该行业进行调整，迫使公司改进产品、加强分销，同时投资于教育和推广工作，以提高人们对 PAP 治疗的接受度。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局
• 专利分析
• 技术分析

正压呼吸器市场规模（依产品类型及复合年增长率） (2025-2032)

• 市场概况
• 持续性呼吸道正压通气 (CPAP)
• 自动正压呼吸装置(APAP)
• 双正压呼吸器(BiPAP)

正压呼吸器市场规模（按应用划分）及复合年增长率（2025-2032）

• 市场概况
• 阻塞型睡眠呼吸中止症
• 呼吸衰竭
• 慢性阻塞性肺病(COPD)
• 其他的

正压呼吸器市场规模（按最终用户和复合年增长率划分）（2025-2032 年）

• 市场概况
• 医院
• 家庭医疗保健
• 睡眠实验室和诊所

正压呼吸器市场规模（按地区划分）及复合年增长率（2025-2032 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• ResMed Inc.（USA）
• Koninklijke Philips NV（Netherlands）
• Fisher & Paykel Healthcare Corporation Limited（New Zealand）
• DeVilbiss Healthcare LLC（USA）
• Drive Medical（USA）
• 3B Medical, Inc.（USA）
• Apex Medical Corp.（Taiwan）
• BMC Medical Co., Ltd.（China）
• Somnetics International, Inc.（USA）
• Invacare Corporation（USA）
• Medtronic plc（Ireland）
• Vyaire Medical, Inc.（USA）
• Compumedics Limited（Australia）
• Lowenstein Medical Innovation GmbH & Co. KG（Germany）
• Teijin Pharma Limited（Japan）
• Nihon Kohden Corporation（Japan）
• Itamar Medical Ltd.（Israel）
• Circadiance LLC（USA）
• Breas Medical AB（Sweden）
• Weinmann Emergency Medical Technology GmbH+Co. KG（Germany）

结论和建议

Positive Airway Pressure Devices Market size was valued at USD 2.27 billion in 2023 and is poised to grow from USD 2.39 billion in 2024 to USD 3.58 billion by 2032, growing at a CAGR of 5.2% during the forecast period (2025-2032).

The global Positive Airway Pressure (PAP) device market is experiencing consistent growth fueled by heightened awareness and diagnosis of sleep-related breathing disorders like sleep apnea. These conditions significantly impact overall health, increasing the demand for effective treatment options such as Continuous Positive Airway Pressure (CPAP) and Bi-level Positive Airway Pressure (BiPAP) machines, which are non-invasive and enhance breathing. Key growth drivers include rising healthcare expenditures, technological advancements improving comfort, and an aging population more prone to sleep disorders. Collaborative efforts among manufacturers, healthcare providers, and research institutions are fostering innovation. However, challenges like patient adherence, cost concerns, and regulatory hurdles necessitate industry adjustments, compelling companies to refine their products and enhance distribution while investing in educational outreach to promote acceptance of PAP therapy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Positive Airway Pressure Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Positive Airway Pressure Devices Market Segments Analysis

Global Positive Airway Pressure Devices Market is segmented by Product Type, Application, End User and region. Based on Product Type, the market is segmented into Continuous Positive Airway Pressure (CPAP) Devices, Automatic Positive Airway Pressure (APAP) Devices and Bi-level Positive Airway Pressure (BiPAP) Devices. Based on Application, the market is segmented into Obstructive Sleep Apnea, Respiratory Failures, Chronic Obstructive Pulmonary Disease (COPD) and Others. Based on End User, the market is segmented into Hospitals, Home Healthcare and Sleep Laboratories & Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Positive Airway Pressure Devices Market

The rising global incidence of sleep disorders significantly influences the growth of the positive airway pressure (PAP) devices market. These devices are essential for treating conditions such as obstructive sleep apnea (OSA), as they provide an effective primary solution for managing these ailments. By promoting a clear airway during sleep, PAP therapy effectively tackles the root causes of these disorders. As the prevalence of sleep disorders continues to climb, the demand for PAP devices is projected to increase, positioning them as a crucial driver for market expansion in the coming years. Thus, the correlation between sleep disorder rates and PAP device demand underscores a positive market outlook.

Restraints in the Positive Airway Pressure Devices Market

Although Positive Airway Pressure (PAP) devices are highly effective for treating sleep-related breathing disorders, including sleep apnea, many patients face challenges in using them consistently as directed. This non-compliance is often the result of discomfort, poorly fitting masks, and feelings of claustrophobia, all of which can lead to diminished motivation to adhere to therapy. Additionally, a lack of understanding regarding the long-term health benefits associated with PAP use further contributes to this issue. Addressing these adherence barriers is crucial for maximizing the effectiveness of PAP devices and achieving positive health outcomes; however, patient compliance remains a significant obstacle for market growth and success.

Market Trends of the Positive Airway Pressure Devices Market

The Positive Airway Pressure (PAP) devices market is witnessing a significant shift towards remote monitoring and telehealth solutions, driven by advancements in healthcare technology. Manufacturers are increasingly incorporating connectivity features into PAP devices, enabling seamless transmission of therapy data from patients to healthcare providers. This innovation facilitates real-time feedback, improving patient adherence to treatment plans and enhancing overall therapy management. As healthcare increasingly embraces digital solutions, this trend is poised to reshape the PAP devices market, fostering greater patient engagement and optimizing health outcomes. The continued integration of telehealth capabilities is expected to propel market growth well into the future.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis
• Technology Analysis

Global Positive Airway Pressure Devices Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Continuous Positive Airway Pressure (CPAP) Devices
• Automatic Positive Airway Pressure (APAP) Devices
• Bi-level Positive Airway Pressure (BiPAP) Devices

Global Positive Airway Pressure Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Obstructive Sleep Apnea
• Respiratory Failures
• Chronic Obstructive Pulmonary Disease (COPD)
• Others

Global Positive Airway Pressure Devices Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Home Healthcare
• Sleep Laboratories & Clinics

Global Positive Airway Pressure Devices Market Size & CAGR (2025-2032)

• North America (Product Type, Application, End User)
  • US
  • Canada
• Europe (Product Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• ResMed Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fisher & Paykel Healthcare Corporation Limited (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DeVilbiss Healthcare LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Drive Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3B Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apex Medical Corp. (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BMC Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Somnetics International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invacare Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vyaire Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Compumedics Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lowenstein Medical Innovation GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teijin Pharma Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Itamar Medical Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Circadiance LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Breas Medical AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Weinmann Emergency Medical Technology GmbH + Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations